Gail Bukofzer

ABT-888 Confers Broad <i>In vivo</i> Activity in Combination with Temozolomide in Diverse Tumors

Joann P. Palma, Yichun Wang, Luis E. Rodrı́guez et al. · Clinical Cancer Research · 2009 · 139 citations

Medicine, Oncology, Pharmacology +16

Sialylation of Lipooligosaccharides Promotes Biofilm Formation by Nontypeable <i>Haemophilus influenzae</i>

W. Edward Swords, Miranda L. Moore, Luciana Godzicki et al. · Infection and Immunity · 2003 · 137 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +8

Optimization of Phenyl-Substituted Benzimidazole Carboxamide Poly(ADP-Ribose) Polymerase Inhibitors: Identification of (<i>S</i>)-2-(2-Fluoro-4-(pyrrolidin-2-yl)phenyl)-1<i>H</i>-benzimidazole-4-carboxamide (A-966492), a Highly Potent and Efficacious Inhibitor

Gui‐Dong Zhu, Jianchun Gong, Sheela A. Thomas et al. · Journal of Medicinal Chemistry · 2010 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo.

Joann P. Palma, Luis E. Rodrı́guez, Velitchka Bontcheva-Diaz et al. · PubMed · 2008 · 56 citations

Medicine, Medicinal Chemistry, Pharmacology +14

7-Aminopyrazolo[1,5-<i>a</i>]pyrimidines as Potent Multitargeted Receptor Tyrosine Kinase Inhibitors

Robin R. Frey, Michael L. Curtin, Daniel H. Albert et al. · Journal of Medicinal Chemistry · 2008 · 49 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15